Vioxx Victims Receive Billions in Compensation

Los Angeles Vioxx Attorneys
Click Here to Visit Our
Vioxx Website

Vioxx, a well-known product defect, was a brand name used by Merck & Co., Inc. ("Merck") to market and distribute rofecoxib tablets, a nonsteroidal anti-inflammatory prescription arthritis drug. Merck obtained FDA approval on Vioxx in approximately April 1999 via a New Drug Application on a fast-track, 6-month approval process. Merck began distribution and sale of Vioxx throughout the United States in approximately May 1999. Despite knowledge in its clinical trials and post-marketing reports associating Vioxx with hypertension and/or hypertension-related adverse health effects, Merck marketed and promoted Vioxx as safe and effective for persons with hypertension, or persons who had risk factors for stroke or cardiac problems.

On September 30, 2004 Merck removed Vioxx from the market in all countries because it was associated with heart attacks, stroke, cardiovascular injuries and other side effects. Merck removed Vioxx after an extended study showing that patients who used Vioxx doubled their risk of having a heart attack, stroke or other cardiovascular injury.

Vioxx Victims Receive Billions of Dollars

More than 60,000 claimants enrolled in the 4.85 billion dollar Vioxx product liability settlement program. Eligible claimants were those that had a filed a lawsuit as of November 9, 2007, alleging that they suffered a stroke or heart attack as a direct result of taking Vioxx. More than 44,000 of 47,000 eligible claimants enrolled in the program. In order for an eligible claimant to qualify for an initial payment if his or her claim is determined to be compensable, that Claimant must enroll his or her claim on or before February 29, 2008. Eligible claimants who enrolled as of February 29, 2008, have a 31-day grace period to submit to the Claims Administrator additional documentation, including properly executed releases and medical authorization forms. All eligible claimants must have enrolled before May 1, 2008, in order to participate in the Settlement Program.

California Pharmaceutical Attorneys

Seriously injured by a defective medication? Want to know if you have a case? Want compensation for your injuries? Want justice? Want to make sure the same thing doesn't happen to someone else?

Call a California pharmaceutical litigation attorney for superior client representation during your time of need.

If you have suffered from similar side effects you may want to search though our list of defective drugs to find out if your prescription is dangerous or defective.

(click on icons for more information)

Disclaimer: The legal information presented at this site should not be construed to be formal legal advice, nor the formation of an attorney-client relationship. Any results set forth here were dependent on the facts of that case and the results will differ from case to case.

Bisnar | Chase serves all of California. In addition, we represent clients in other states through our associations with local law firms. Through the local firm, we will be admitted to practice law in their state, pro hac vice, meaning "for this particular occasion." When in our client's interest, we employ the local law firm (at no additional cost to our client) to assist us with routine court appearances and discovery proceedings to more efficiently pursue our client's cause.

Copyright © 1999- Bisnar | Chase Personal Injury Attorneys, LLP - All rights reserved. Location: 1301 Dove St. #120, Newport Beach, CA 92660 Tel: 1-800-561-4887

Disclaimer | Privacy Policy | Terms of Use | Sitemap | Abogados para Accidentes de Auto - Se Habla Español

 SLS Consulting